Missing Information
  • A System Error Has Occured:0177 - Failed to Load All Sections.
Company:  RUBIUS THERAPEUTICS, INC. (RUBY)
Form Type:  4
Filing Date:  6/19/2019 
CIK:  0001709401 
Address:  399 BINNEY STREET, SUITE 300 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  617-679-9600 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$10.62  
Change: 
0.28 (2.71%)  
Trade Time: 
Dec 06  
Market Cap: 
$847.49M
Trade RUBY now with

© 2019  
Description of Business
We are developing a new class of cellular medicines, Red Cell Therapeutics, or RCTs. Based on our vision that human red blood cells are the foundation of the next significant innovation in medicine, we have designed a proprietary platform to genetically engineer and culture RCTs that are selective, potent and ready­to­use cellular therapies. We believe that our RCTs will provide life­changing or life­saving benefits for patients with severe diseases across multiple therapeutic areas. We have generated hundreds of RCTs using our RED PLATFORM®, a highly versatile and proprietary cellular therapy platform. We are utilizing our universal engineering and manufacturing processes to advance a broad pipeline of RCT product candidates into clinical trials in rare diseases, cancer and autoimmune diseases. Common design and manufacturing elements of our RCTs should enable us to achieve significant advantages in product development.